WallStreetZenWallStreetZen

NASDAQ: BNR
Burning Rock Biotech Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BNR past revenue growth

How has BNR's revenue growth performed historically?
Company
0.3%
Industry
1.91%
Market
13.73%
BNR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BNR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BNR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BNR earnings and revenue history

Current Revenue
$80.9M
Current Earnings
-$105.6M
Current Profit Margin
-130.5%

BNR Return on Equity

Current Company
-68.4%
Current Industry
-75.3%
Current Market
22.1%
BNR's Return on Equity (-68.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BNR announces earnings.

BNR Return on Assets

Current Company
-50.4%
Current Industry
5.6%
BNR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BNR Return on Capital Employed

Current Company
-77.88%
Current Industry
10.3%
BNR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BNR vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BNR$80.67MN/A-$105.26M+82.73%N/A
FONR$98.65M$21.86M$8.80M+3.89%-15.64%
DRIO$26.63M-$52.75M-$60.11M+31.52%N/A
NOTV$582.15M-$271.83M-$339.63M+90.45%N/A
PRE$143.60MN/A-$45.50M-2.75%N/A
View Top Diagnostic & Research Stocks

BNR earnings dates

Next earnings date
Nov 14, 2023

Burning Rock Biotech Earnings & Revenue FAQ

What were BNR's earnings last quarter?

On Invalid Date, Burning Rock Biotech (NASDAQ: BNR) reported Q2 2023 earnings per share (EPS) of -$0.18, up 52.55% year over year. Total Burning Rock Biotech earnings for the quarter were -$18.13 million. In the same quarter last year, Burning Rock Biotech's earnings per share (EPS) was -$0.37.

If you're new to stock investing, here's how to buy Burning Rock Biotech stock.

What was BNR's earnings growth in the past year?

As of Q3 2023, Burning Rock Biotech's earnings has grown year over year. Burning Rock Biotech's earnings in the past year totalled -$105.26 million.

What is BNR's earnings date?

Burning Rock Biotech's earnings date is Invalid Date. Add BNR to your watchlist to be reminded of BNR's next earnings announcement.

What was BNR's revenue last quarter?

On Invalid Date, Burning Rock Biotech (NASDAQ: BNR) reported Q2 2023 revenue of $20.20 million up 3.45% year over year. In the same quarter last year, Burning Rock Biotech's revenue was $19.53 million.

What was BNR's revenue growth in the past year?

As of Q3 2023, Burning Rock Biotech's revenue has grown 0.3% year over year. This is 1.61 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 1.91%. Burning Rock Biotech's revenue in the past year totalled $80.67 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.